FDA clears OTC CGM for children aged 2 years and older who do not use insulin

The FDA has announced additional marketing clearance for the Dexcom Stelo Glucose Biosensor System for children aged 2 years and older, according to a press release.The Dexcom Stelo Glucose Biosensor System received FDA marketing clearance for adults in March 2024. The clearance now extends to children aged 2 years and older.

Raccontata dahealio.com